Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
about
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
@en
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
@nl
type
label
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
@en
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
@nl
prefLabel
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
@en
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
@nl
P2093
P2860
P356
P1476
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
@en
P2093
Chenxu Liu
Dongdong Wang
Guanying Zhang
Yinhan Gong
P2860
P304
P356
10.3892/IJMM.2018.3504
P577
2018-02-16T00:00:00Z